Distinct roles of endogenous vascular endothelial factor receptor 1 and 2 in neural protection after spinal cord injury

Munehisa Shinozaki, Masaya Nakamura, Tsunehiko Konomi, Yoshiomi Kobayashi, Morito Takano, Nobuhito Saito, Yoshiaki Toyama, Hideyuki Okano

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Secondary degeneration after spinal cord injury (SCI) is caused by increased vascular permeability, infiltration of inflammatory cells, and subsequent focal edema. Therapeutic interventions using neurotrophic factors have focused on the prevention of such reactions to reduce cell death and promote tissue regeneration. Vascular endothelial growth factor (VEGF) is a potent angiogenic and vascular permeability factor. However, the effect of VEGF on SCI remains controversial. VEGF signaling is primarily regulated through two primary receptors, VEGF receptor 1 (VEGF-R1) and VEGF receptor 2 (VEGF-R2). The purpose of this study was to examine the effects of intraperitoneal administration of VEGF-R1- and VEGF-R2-neutralizing antibodies on a mouse model of SCI. VEGF-R1 blockade, but not VEGF-R2 blockade, decreased the permeability and infiltration of inflammatory cells, and VEGF-R2 blockade caused a significant increase in neuronal apoptosis in the acute phase of SCI. VEGF-R2 blockade decreased the residual tissue area and the number of neural fibers in the chronic phase of SCI. VEGF-R2 blockade worsened the functional recovery and prolonged the latency of motor evoked potentials. These data suggest that endogenous VEGF-R2 plays a crucial role in neuronal protection after SCI.

Original languageEnglish
Pages (from-to)55-64
Number of pages10
JournalNeuroscience Research
Volume78
Issue number1
DOIs
Publication statusPublished - 2014 Jan

Fingerprint

Spinal Cord Injuries
Vascular Endothelial Growth Factor A
vascular factor
Neuroprotection
Vascular Endothelial Growth Factor Receptor-1
Motor Evoked Potentials
Vascular Endothelial Growth Factor Receptor-2
Nerve Growth Factors
Capillary Permeability
Neutralizing Antibodies
Regeneration
Permeability
Edema
Cell Death
Apoptosis

Keywords

  • Functional recovery
  • Neurotrophic factor
  • Spinal cord injury
  • Vascular endothelial growth factor
  • Vascular endothelial growth factor receptor

ASJC Scopus subject areas

  • Neuroscience(all)
  • Medicine(all)

Cite this

Distinct roles of endogenous vascular endothelial factor receptor 1 and 2 in neural protection after spinal cord injury. / Shinozaki, Munehisa; Nakamura, Masaya; Konomi, Tsunehiko; Kobayashi, Yoshiomi; Takano, Morito; Saito, Nobuhito; Toyama, Yoshiaki; Okano, Hideyuki.

In: Neuroscience Research, Vol. 78, No. 1, 01.2014, p. 55-64.

Research output: Contribution to journalArticle

Shinozaki, Munehisa ; Nakamura, Masaya ; Konomi, Tsunehiko ; Kobayashi, Yoshiomi ; Takano, Morito ; Saito, Nobuhito ; Toyama, Yoshiaki ; Okano, Hideyuki. / Distinct roles of endogenous vascular endothelial factor receptor 1 and 2 in neural protection after spinal cord injury. In: Neuroscience Research. 2014 ; Vol. 78, No. 1. pp. 55-64.
@article{24e8cef515b644e2ad8f37be17fce276,
title = "Distinct roles of endogenous vascular endothelial factor receptor 1 and 2 in neural protection after spinal cord injury",
abstract = "Secondary degeneration after spinal cord injury (SCI) is caused by increased vascular permeability, infiltration of inflammatory cells, and subsequent focal edema. Therapeutic interventions using neurotrophic factors have focused on the prevention of such reactions to reduce cell death and promote tissue regeneration. Vascular endothelial growth factor (VEGF) is a potent angiogenic and vascular permeability factor. However, the effect of VEGF on SCI remains controversial. VEGF signaling is primarily regulated through two primary receptors, VEGF receptor 1 (VEGF-R1) and VEGF receptor 2 (VEGF-R2). The purpose of this study was to examine the effects of intraperitoneal administration of VEGF-R1- and VEGF-R2-neutralizing antibodies on a mouse model of SCI. VEGF-R1 blockade, but not VEGF-R2 blockade, decreased the permeability and infiltration of inflammatory cells, and VEGF-R2 blockade caused a significant increase in neuronal apoptosis in the acute phase of SCI. VEGF-R2 blockade decreased the residual tissue area and the number of neural fibers in the chronic phase of SCI. VEGF-R2 blockade worsened the functional recovery and prolonged the latency of motor evoked potentials. These data suggest that endogenous VEGF-R2 plays a crucial role in neuronal protection after SCI.",
keywords = "Functional recovery, Neurotrophic factor, Spinal cord injury, Vascular endothelial growth factor, Vascular endothelial growth factor receptor",
author = "Munehisa Shinozaki and Masaya Nakamura and Tsunehiko Konomi and Yoshiomi Kobayashi and Morito Takano and Nobuhito Saito and Yoshiaki Toyama and Hideyuki Okano",
year = "2014",
month = "1",
doi = "10.1016/j.neures.2013.09.011",
language = "English",
volume = "78",
pages = "55--64",
journal = "Neuroscience Research",
issn = "0168-0102",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Distinct roles of endogenous vascular endothelial factor receptor 1 and 2 in neural protection after spinal cord injury

AU - Shinozaki, Munehisa

AU - Nakamura, Masaya

AU - Konomi, Tsunehiko

AU - Kobayashi, Yoshiomi

AU - Takano, Morito

AU - Saito, Nobuhito

AU - Toyama, Yoshiaki

AU - Okano, Hideyuki

PY - 2014/1

Y1 - 2014/1

N2 - Secondary degeneration after spinal cord injury (SCI) is caused by increased vascular permeability, infiltration of inflammatory cells, and subsequent focal edema. Therapeutic interventions using neurotrophic factors have focused on the prevention of such reactions to reduce cell death and promote tissue regeneration. Vascular endothelial growth factor (VEGF) is a potent angiogenic and vascular permeability factor. However, the effect of VEGF on SCI remains controversial. VEGF signaling is primarily regulated through two primary receptors, VEGF receptor 1 (VEGF-R1) and VEGF receptor 2 (VEGF-R2). The purpose of this study was to examine the effects of intraperitoneal administration of VEGF-R1- and VEGF-R2-neutralizing antibodies on a mouse model of SCI. VEGF-R1 blockade, but not VEGF-R2 blockade, decreased the permeability and infiltration of inflammatory cells, and VEGF-R2 blockade caused a significant increase in neuronal apoptosis in the acute phase of SCI. VEGF-R2 blockade decreased the residual tissue area and the number of neural fibers in the chronic phase of SCI. VEGF-R2 blockade worsened the functional recovery and prolonged the latency of motor evoked potentials. These data suggest that endogenous VEGF-R2 plays a crucial role in neuronal protection after SCI.

AB - Secondary degeneration after spinal cord injury (SCI) is caused by increased vascular permeability, infiltration of inflammatory cells, and subsequent focal edema. Therapeutic interventions using neurotrophic factors have focused on the prevention of such reactions to reduce cell death and promote tissue regeneration. Vascular endothelial growth factor (VEGF) is a potent angiogenic and vascular permeability factor. However, the effect of VEGF on SCI remains controversial. VEGF signaling is primarily regulated through two primary receptors, VEGF receptor 1 (VEGF-R1) and VEGF receptor 2 (VEGF-R2). The purpose of this study was to examine the effects of intraperitoneal administration of VEGF-R1- and VEGF-R2-neutralizing antibodies on a mouse model of SCI. VEGF-R1 blockade, but not VEGF-R2 blockade, decreased the permeability and infiltration of inflammatory cells, and VEGF-R2 blockade caused a significant increase in neuronal apoptosis in the acute phase of SCI. VEGF-R2 blockade decreased the residual tissue area and the number of neural fibers in the chronic phase of SCI. VEGF-R2 blockade worsened the functional recovery and prolonged the latency of motor evoked potentials. These data suggest that endogenous VEGF-R2 plays a crucial role in neuronal protection after SCI.

KW - Functional recovery

KW - Neurotrophic factor

KW - Spinal cord injury

KW - Vascular endothelial growth factor

KW - Vascular endothelial growth factor receptor

UR - http://www.scopus.com/inward/record.url?scp=84892674861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892674861&partnerID=8YFLogxK

U2 - 10.1016/j.neures.2013.09.011

DO - 10.1016/j.neures.2013.09.011

M3 - Article

VL - 78

SP - 55

EP - 64

JO - Neuroscience Research

JF - Neuroscience Research

SN - 0168-0102

IS - 1

ER -